Amyloid-specific T-cells differentiate Alzheimer's disease from Lewy body dementia

[1]  Mario Roederer,et al.  SPICE: Exploration and analysis of post‐cytometric complex multivariate datasets , 2011, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[2]  M. Schwartz,et al.  Systemic inflammatory cells fight off neurodegenerative disease , 2010, Nature Reviews Neurology.

[3]  J. Rupp,et al.  Chlamydia pneumoniae-Induced Memory CD4+ T-Cell Activation in Human Peripheral Blood Correlates with Distinct Antibody Response Patterns , 2010, Clinical and Vaccine Immunology.

[4]  M. Hristov,et al.  An optimized flow cytometry protocol for analysis of angiogenic monocytes and endothelial progenitor cells in peripheral blood , 2009, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[5]  P. Francis.  Biochemical and pathological correlates of cognitive and behavioural change in DLB/PDD , 2009, Journal of Neurology.

[6]  F. Kern,et al.  Simultaneous Characterization of Phospho-Proteins and Cell Cycle in Activated T Cell Subsets , 2009, International journal of immunopathology and pharmacology.

[7]  H. Inoko,et al.  PKC delta and epsilon in drug targeting and therapeutics. , 2009, Recent patents on DNA & gene sequences.

[8]  D. Gambi,et al.  Aβ1–42 stimulated T cells express P-PKC-δ and P-PKC-ζ in Alzheimer disease , 2009, Neurobiology of Aging.

[9]  D. Morgan.  The role of microglia in antibody-mediated clearance of amyloid-beta from the brain. , 2009, CNS & neurological disorders drug targets.

[10]  Mario Roederer,et al.  A chromatic explosion: the development and future of multiparameter flow cytometry , 2008, Immunology.

[11]  J. Hornegger,et al.  Neurochemical dementia diagnostics: assays in CSF and blood , 2008, European Archives of Psychiatry and Clinical Neuroscience.

[12]  G. Perry,et al.  Antigen–antibody dissociation in Alzheimer disease: a novel approach to diagnosis , 2008, Journal of neurochemistry.

[13]  L. Serpell,et al.  Amyloid fibrils , 2008, Prion.

[14]  N. Relkin,et al.  Natural human antibodies to amyloid beta peptide. , 2008, Autoimmunity reviews.

[15]  F. Kern,et al.  T cell response to the cytomegalovirus major capsid protein (UL86) is dominated by helper cells with a large polyfunctional component and diverse epitope recognition. , 2008, The Journal of infectious diseases.

[16]  Gerald van Belle,et al.  Consortium to Establish a Registry for Alzheimer’s Disease (CERAD): The first twenty years , 2008, Alzheimer's & Dementia.

[17]  M. Onofrj,et al.  EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up. , 2008, Brain : a journal of neurology.

[18]  Stavros J. Baloyannis,et al.  Systemic immune aberrations in Alzheimer's disease patients , 2008, Journal of Neuroimmunology.

[19]  D. Gambi,et al.  Expression and Phosphorylation of Protein Kinase C Isoforms in Aβ1–42 Activated T Lymphocytes from Alzheimer's Disease , 2008, International journal of immunopathology and pharmacology.

[20]  Maria L. D. Udan,et al.  Toll‐like receptors 2 and 4 mediate Aβ(1–42) activation of the innate immune response in a human monocytic cell line , 2007, Journal of neurochemistry.

[21]  L. Wetzler,et al.  T Cell Activation by TLRs: A Role for TLRs in the Adaptive Immune Response , 2007, Science's STKE.

[22]  C. Tinelli,et al.  Lymphocyte subset patterns and cytokine production in Alzheimer's disease patients , 2007, Neurobiology of Aging.

[23]  I. McKeith,et al.  Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study , 2007, The Lancet Neurology.

[24]  R. Desrosiers,et al.  Induction of a virus-specific effector–memory CD4+ T cell response by attenuated SIV infection , 2006, The Journal of experimental medicine.

[25]  Mario Roederer,et al.  Quality assurance for polychromatic flow cytometry , 2006, Nature Protocols.

[26]  Holden T Maecker,et al.  Flow cytometry controls, instrument setup, and the determination of positivity , 2006, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[27]  G. Deuschl,et al.  Scales in Parkinson’s disease , 2006, Journal of Neurology.

[28]  Frank M LaFerla,et al.  Genetically augmenting Abeta42 levels in skeletal muscle exacerbates inclusion body myositis-like pathology and motor deficits in transgenic mice. , 2006, The American journal of pathology.

[29]  S Minoshima,et al.  Diagnosis and management of dementia with Lewy bodies , 2005, Neurology.

[30]  Werner Poewe,et al.  How to diagnose dementia with Lewy bodies: State of the art , 2005, Movement disorders : official journal of the Movement Disorder Society.

[31]  D. Gambi,et al.  Expression and production of two selected beta-chemokines in peripheral blood mononuclear cells from patients with Alzheimer's disease , 2005, Experimental Gerontology.

[32]  D. Gambi,et al.  Acetylcholinesterase inhibitors effects on oncostatin-M, interleukin-1β and interleukin-6 release from lymphocytes of Alzheimer's disease patients , 2005, Experimental Gerontology.

[33]  C. Paladini,et al.  Alzheimer Patients Treated With an AchE Inhibitor Show Higher IL-4 and Lower IL-1β Levels and Expression in Peripheral Blood Mononuclear Cells , 2004, Journal of clinical psychopharmacology.

[34]  D. Gambi,et al.  IL-4 in vitro production is upregulated in Alzheimer's disease patients treated with acetylcholinesterase inhibitors , 2004, Experimental Gerontology.

[35]  Seng-Lai Tan,et al.  Emerging and diverse roles of protein kinase C in immune cell signalling. , 2003, The Biochemical journal.

[36]  S. Savkovic,et al.  PKC zeta participates in activation of inflammatory response induced by enteropathogenic E. coli. , 2003, American journal of physiology. Cell physiology.

[37]  R. Sperling,et al.  Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease. , 2003, The Journal of clinical investigation.

[38]  S. D. Preston,et al.  Capillary and arterial cerebral amyloid angiopathy in Alzheimer's disease: defining the perivascular route for the elimination of amyloid β from the human brain , 2003, Neuropathology and applied neurobiology.

[39]  M. Onofrj,et al.  HLA typing does not predict REM sleep behaviour disorder and hallucinations in Parkinson's disease , 2003, Movement disorders : official journal of the Movement Disorder Society.

[40]  W. Engel,et al.  Inclusion-body myositis and myopathies: different etiologies, possibly similar pathogenic mechanisms , 2002, Current opinion in neurology.

[41]  M. Fresno,et al.  Protein Kinase Cζ Phosphorylates Nuclear Factor of Activated T Cells and Regulates Its Transactivating Activity* , 2002, The Journal of Biological Chemistry.

[42]  G. Crabtree,et al.  NFAT Signaling Choreographing the Social Lives of Cells , 2002, Cell.

[43]  Masanori Kato,et al.  Occurrence of T cells in the brain of Alzheimer's disease and other neurological diseases , 2002, Journal of Neuroimmunology.

[44]  M Roederer,et al.  Spectral compensation for flow cytometry: visualization artifacts, limitations, and caveats. , 2001, Cytometry.

[45]  L. Parnetti,et al.  CSF phosphorylated tau is a possible marker for discriminating Alzheimer's disease from dementia with Lewy bodies , 2001, Neurological Sciences.

[46]  I Litvan,et al.  The FAB: A frontal assessment battery at bedside , 2000, Neurology.

[47]  I G McKeith,et al.  The Clinician Assessment of Fluctuation and the One Day Fluctuation Assessment Scale. Two methods to assess fluctuating confusion in dementia. , 2000, The British journal of psychiatry : the journal of mental science.

[48]  C. Plata-salamán,et al.  Inflammation and Alzheimer’s disease , 2000, Neurobiology of Aging.

[49]  L. Picker,et al.  Distribution of human CMV‐specific memory T cells among the CD8pos. subsets defined by CD57, CD27, and CD45 isoforms , 1999, European journal of immunology.

[50]  R. Pietro,et al.  Immunocytochemical Localization of Phospholipase C Isozymes in Cord Blood and Adult T-lymphocytes , 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[51]  J. Schneider-Mergener,et al.  T-cell epitope mapping by flow cytometry , 1998, Nature Medicine.

[52]  K. Kosaka,et al.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) , 1996, Neurology.

[53]  M. Yamada,et al.  Immune reactions associated with cerebral amyloid angiopathy. , 1996, Stroke.

[54]  M. Mega,et al.  The Neuropsychiatric Inventory , 1994, Neurology.

[55]  S. Fu,et al.  Human antibodies reactive with beta-amyloid protein in Alzheimer's disease , 1993, The Journal of experimental medicine.

[56]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[57]  J. Hanley,et al.  The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.

[58]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[59]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[60]  J. Pantel,et al.  Enhanced apoptosis, oxidative stress and mitochondrial dysfunction in lymphocytes as potential biomarkers for Alzheimer's disease. , 2007, Journal of neural transmission. Supplementum.

[61]  R. Flavell,et al.  T-cells in alzheimer’s disease , 2007, NeuroMolecular Medicine.

[62]  I. Blasko,et al.  Role of the Immune System in the Pathogenesis, Prevention and Treatment of Alzheimer’s Disease , 2003, Drugs & aging.

[63]  A. Altman,et al.  PROTEIN KINASE C IN T CELL ACTIVATION , 2002 .